IL13 and allergic disease: Substantial progress has been made over the past 28 years in understanding the contribution of 4PS (IRS1 or IRS2) to IL-4- and IL-13-stimulated responses in the context of allergic diseases, however, as noted throughout, there is still much work to be done.